Bengisu Ece DUMAN , Candas MUMCU , Mujgan COZELI , Berra Nur ISCI , Emre BAL , Meryem SENER , Arzu DEMIR , Melek ERGIN , Birol GUVENC
{"title":"挑战 DLBCL 的表现范式:非同寻常的疾病分布病例研究","authors":"Bengisu Ece DUMAN , Candas MUMCU , Mujgan COZELI , Berra Nur ISCI , Emre BAL , Meryem SENER , Arzu DEMIR , Melek ERGIN , Birol GUVENC","doi":"10.1016/j.htct.2024.04.046","DOIUrl":null,"url":null,"abstract":"<div><p>This case study examines a 55-year-old male without previously known comorbidities, who was evaluated due to palpable lymph nodes identified incidentally in the neck, inguinal, and axillary regions. The extensive diagnostic work-up, including advanced imaging, revealed a pattern not commonly associated with diffuse large B-cell lymphoma (DLBCL), including hypermetabolic thickening in the posterior nasopharynx, significant hypermetabolism around the pancreas, and suspicious activity in the spleen and lung. Notably, the involvement extended to both parotid glands and a vast array of lymph nodes, marking an atypical presentation that underscores DLBCL's potential for widespread disease. Biopsies confirmed DLBCL with a non-germinal center phenotype, an aggressive variant with implications for treatment and prognosis. Despite a thorough diagnostic process, the patient elected to forgo the recommended DA-R-EPOCH chemotherapy, highlighting significant ethical and autonomy considerations within the realm of oncological care. This case contributes to the medical literature by illustrating the diagnostic challenges and treatment decision complexities in cases of DLBCL with unusual disease distribution and patient care preferences.</p></div>","PeriodicalId":12958,"journal":{"name":"Hematology, Transfusion and Cell Therapy","volume":null,"pages":null},"PeriodicalIF":1.8000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2531137924001287/pdfft?md5=af459a3ad9898d87d223deeca82f277b&pid=1-s2.0-S2531137924001287-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Challenging the Presentation Paradigm in DLBCL: A Case Study of Extraordinary Disease Distribution\",\"authors\":\"Bengisu Ece DUMAN , Candas MUMCU , Mujgan COZELI , Berra Nur ISCI , Emre BAL , Meryem SENER , Arzu DEMIR , Melek ERGIN , Birol GUVENC\",\"doi\":\"10.1016/j.htct.2024.04.046\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>This case study examines a 55-year-old male without previously known comorbidities, who was evaluated due to palpable lymph nodes identified incidentally in the neck, inguinal, and axillary regions. The extensive diagnostic work-up, including advanced imaging, revealed a pattern not commonly associated with diffuse large B-cell lymphoma (DLBCL), including hypermetabolic thickening in the posterior nasopharynx, significant hypermetabolism around the pancreas, and suspicious activity in the spleen and lung. Notably, the involvement extended to both parotid glands and a vast array of lymph nodes, marking an atypical presentation that underscores DLBCL's potential for widespread disease. Biopsies confirmed DLBCL with a non-germinal center phenotype, an aggressive variant with implications for treatment and prognosis. Despite a thorough diagnostic process, the patient elected to forgo the recommended DA-R-EPOCH chemotherapy, highlighting significant ethical and autonomy considerations within the realm of oncological care. This case contributes to the medical literature by illustrating the diagnostic challenges and treatment decision complexities in cases of DLBCL with unusual disease distribution and patient care preferences.</p></div>\",\"PeriodicalId\":12958,\"journal\":{\"name\":\"Hematology, Transfusion and Cell Therapy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2024-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2531137924001287/pdfft?md5=af459a3ad9898d87d223deeca82f277b&pid=1-s2.0-S2531137924001287-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hematology, Transfusion and Cell Therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2531137924001287\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hematology, Transfusion and Cell Therapy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2531137924001287","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
本病例研究的患者是一名55岁的男性,之前并无已知的合并症,因颈部、腹股沟和腋窝区域偶然发现可触及的淋巴结而接受评估。广泛的诊断检查(包括先进的影像学检查)发现了一种与弥漫大 B 细胞淋巴瘤(DLBCL)不常见的模式,包括鼻咽后部的高代谢增厚、胰腺周围的显著高代谢以及脾脏和肺部的可疑活动。值得注意的是,受累范围扩大到双侧腮腺和大量淋巴结,这是一种非典型表现,凸显了DLBCL广泛发病的可能性。活检证实 DLBCL 具有非芽胞中心表型,这是一种侵袭性变异,对治疗和预后有影响。尽管进行了全面的诊断,但患者仍选择放弃建议的 DA-R-EPOCH 化疗,这凸显了肿瘤治疗领域的重大伦理和自主权问题。本病例说明了疾病分布异常的DLBCL病例的诊断挑战和治疗决策的复杂性以及患者的护理偏好,为医学文献做出了贡献。
Challenging the Presentation Paradigm in DLBCL: A Case Study of Extraordinary Disease Distribution
This case study examines a 55-year-old male without previously known comorbidities, who was evaluated due to palpable lymph nodes identified incidentally in the neck, inguinal, and axillary regions. The extensive diagnostic work-up, including advanced imaging, revealed a pattern not commonly associated with diffuse large B-cell lymphoma (DLBCL), including hypermetabolic thickening in the posterior nasopharynx, significant hypermetabolism around the pancreas, and suspicious activity in the spleen and lung. Notably, the involvement extended to both parotid glands and a vast array of lymph nodes, marking an atypical presentation that underscores DLBCL's potential for widespread disease. Biopsies confirmed DLBCL with a non-germinal center phenotype, an aggressive variant with implications for treatment and prognosis. Despite a thorough diagnostic process, the patient elected to forgo the recommended DA-R-EPOCH chemotherapy, highlighting significant ethical and autonomy considerations within the realm of oncological care. This case contributes to the medical literature by illustrating the diagnostic challenges and treatment decision complexities in cases of DLBCL with unusual disease distribution and patient care preferences.